Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II of Study of Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma

NCT03834233 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.

NCT NCT03834233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03834233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II of Study of Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Lead sponsor
Instituto do Cancer do Estado de São Paulo
Phase
Phase 2
Overall status
Unknown status
Start date
September 5, 2019
Completion date
December 1, 2022
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cutaneous squamous cell carcinoma